126 related articles for article (PubMed ID: 37489928)
1. FDG-PET/CT response assessment with qualitative Lugano criteria outperforms change in SUV
Russler-Germain DA; Calhoun BR; Wu N; Watkins MP; Siegel BA; Bartlett NL; Mhlanga JC
Leuk Lymphoma; 2023; 64(11):1870-1874. PubMed ID: 37489928
[No Abstract] [Full Text] [Related]
2. 18F-FDG PET/CT in a case of bilateral lacrimal gland infiltration by mantle cell lymphoma.
Martínez-Esteve A; García-Gómez FJ; Borrero-Martin JJ; Fajardo-Pico E; Borrego-Dorado I
Rev Esp Med Nucl Imagen Mol; 2015; 34(6):396-7. PubMed ID: 25956958
[No Abstract] [Full Text] [Related]
3. "Hood Sign" in Nuclear Medicine: An Unusual Presentation of Mantle Cell Lymphoma as Detected on FDG PET/CT.
Prakash A; Purandare N; Shah S; Agrawal A; Puranik A; Rangarajan V
Clin Nucl Med; 2022 Dec; 47(12):e731-e732. PubMed ID: 35961639
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and Clinical Impact of Staging
Albano D; Ferro P; Bosio G; Fallanca F; Re A; Tucci A; Maria Ferreri AJ; Angelillo P; Gianolli L; Giubbini R; Bertagna F
Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):e457-e464. PubMed ID: 31129112
[TBL] [Abstract][Full Text] [Related]
5. Application of 18F-fluorodeoxyglucose positron emission tomography/computerized tomography in mantle cell lymphoma.
Yang S; Fu L; AbuduRxiti M; Wu J; Wang Q; Qin Y; Zou X; Li H
Nucl Med Commun; 2020 May; 41(5):477-484. PubMed ID: 32168265
[TBL] [Abstract][Full Text] [Related]
6. [
Vergote VKJ; Verhoef G; Janssens A; Woei-A-Jin FJSH; Laenen A; Tousseyn T; Dierickx D; Deroose CM
Leuk Lymphoma; 2023 Jan; 64(1):161-170. PubMed ID: 36223113
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in mantle cell lymphoma.
Albano D; Bosio G; Bianchetti N; Pagani C; Re A; Tucci A; Giubbini R; Bertagna F
Ann Nucl Med; 2019 Jul; 33(7):449-458. PubMed ID: 30929200
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET Project.
Bailly C; Carlier T; Berriolo-Riedinger A; Casasnovas O; Gyan E; Meignan M; Moreau A; Burroni B; Djaileb L; Gressin R; Devillers A; Lamy T; Thieblemont C; Hermine O; Kraeber-Bodéré F; Le Gouill S; Bodet-Milin C
Haematologica; 2020 Jan; 105(1):e33-e36. PubMed ID: 31371411
[No Abstract] [Full Text] [Related]
9. Relevance of monitoring metabolic reduction in patients with relapsed or refractory follicular and mantle cell lymphoma receiving bendamustine: a multicenter study.
Tateishi U; Tatsumi M; Terauchi T; Ishizawa K; Ogura M; Tobinai K
Cancer Sci; 2011 Feb; 102(2):414-8. PubMed ID: 21156007
[TBL] [Abstract][Full Text] [Related]
10. Bilateral Renal Involvement in Mantle Cell Lymphoma on FDG PET/CT.
Mukherjee A; Agarwal KK; Gogia A; Bal C; Kumar R
Clin Nucl Med; 2016 Apr; 41(4):e206-7. PubMed ID: 26914553
[TBL] [Abstract][Full Text] [Related]
11. ¹⁸F-FDG PET/CT imaging for a gastrointestinal mantle cell lymphoma with multiple lymphomatous polyposis.
Saito M; Miyazaki M; Tanino M; Tanaka S; Miyashita K; Izumiyama K; Mori A; Irie T; Tanaka M; Morioka M; Tsukamoto E
World J Gastroenterol; 2014 May; 20(17):5141-6. PubMed ID: 24803832
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of mantle-cell lymphoma relapse by 18F-FDG PET/CT after water gastric distention.
Banzo I; Martínez-Rodríguez I; Quirce R; Jiménez-Bonilla J; Carril JM
Clin Nucl Med; 2014 Oct; 39(10):931-3. PubMed ID: 24999694
[TBL] [Abstract][Full Text] [Related]
13. [18F]fluorodeoxyglucose positron emission tomography scanning for staging, response assessment, and disease surveillance in patients with mantle cell lymphoma.
Gill S; Wolf M; Prince HM; Januszewicz H; Ritchie D; Hicks RJ; Seymour JF
Clin Lymphoma Myeloma; 2008 Jun; 8(3):159-65. PubMed ID: 18650179
[TBL] [Abstract][Full Text] [Related]
14.
Albano D; Treglia G; Gazzilli M; Cerudelli E; Giubbini R; Bertagna F
Clin Lymphoma Myeloma Leuk; 2020 Jul; 20(7):422-430. PubMed ID: 32169480
[TBL] [Abstract][Full Text] [Related]
15. Positron Emission Tomography-based Analysis Can Accurately Predict Bone Marrow Involvement With Mantle Cell Lymphoma.
Morgan R; Perry M; Kwak J; Jensen A; Kamdar M
Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):731-736. PubMed ID: 30075973
[TBL] [Abstract][Full Text] [Related]
16. FDG positron emission tomography/computed tomography scan may identify mantle cell lymphoma patients with unusually favorable outcome.
Karam M; Ata A; Irish K; Feustel PJ; Mottaghy FM; Stroobants SG; Verhoef GE; Chundru S; Douglas-Nikitin V; Oliver Wong CY; Brepoels LM
Nucl Med Commun; 2009 Oct; 30(10):770-8. PubMed ID: 19657307
[TBL] [Abstract][Full Text] [Related]
17. Detection of small bowel involvement by mantle cell lymphoma on F-18 FDG positron emission tomography.
Sam JW; Levine MS; Farner MC; Schuster SJ; Alavi A
Clin Nucl Med; 2002 May; 27(5):330-3. PubMed ID: 11953565
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG PET for Measurement of Response and Prediction of Outcome to Relapsed or Refractory Mantle Cell Lymphoma Therapy with Bendamustine-Rituximab.
Lamonica D; Graf DA; Munteanu MC; Czuczman MS
J Nucl Med; 2017 Jan; 58(1):62-68. PubMed ID: 27469362
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic role of 18F-fluorodeoxyglucose positron emission tomography for follicular lymphoma with gastrointestinal involvement.
Iwamuro M; Okada H; Takata K; Shinagawa K; Fujiki S; Shiode J; Imagawa A; Araki M; Morito T; Nishimura M; Mizuno M; Inaba T; Suzuki S; Kawai Y; Yoshino T; Kawahara Y; Takaki A; Yamamoto K
World J Gastroenterol; 2012 Nov; 18(44):6427-36; discussion p.6434. PubMed ID: 23197888
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET/CT in Intramuscular Mantle Cell Lymphoma With Elongated Lymphomatous Neurovascular Extension.
Hod N; Levin D; Anconina R; Ezroh Kazap D; Lantsberg S
Clin Nucl Med; 2019 Apr; 44(4):e298-e300. PubMed ID: 30688737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]